Across TCGA pan-cancer cohorts, CATSPERE Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CATSPERE data layer compared with 23 for mass-spec protein.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher CATSPERE Mutation is associated with better overall survival. In most high-consensus cancer types, elevated CATSPERE expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.
UCEC, KIRP, and SARC are the cancer types where CATSPERE Mutation most reproducibly stratifies survival.